0 XP   0   0   0

IOL CHEMICALS & PHARMACEUTICALS LTD.
Buy, Hold or Sell?

Should you buy, hold or sell IOL CHEMICALS & PHARMACEUTICALS LTD.?

I guess you are interested in IOL CHEMICALS & PHARMACEUTICALS LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse IOL CHEMICALS & PHARMACEUTICALS LTD.

Let's start. I'm going to help you getting a better view of IOL CHEMICALS & PHARMACEUTICALS LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is IOL CHEMICALS & PHARMACEUTICALS LTD. even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how IOL CHEMICALS & PHARMACEUTICALS LTD. is doing in the market. If the company is worth buying. The latest step is to find out how other investors value IOL CHEMICALS & PHARMACEUTICALS LTD.. The closing price on 2023-02-03 was INR311.90 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
IOL CHEMICALS & PHARMACEUTICALS LTD. Daily Candlestick Chart
IOL CHEMICALS & PHARMACEUTICALS LTD. Daily Candlestick Chart
Summary









1. Valuation of IOL CHEMICALS & PHARMACEUTICALS LTD.




Current price per share

INR311.90

2. Growth of IOL CHEMICALS & PHARMACEUTICALS LTD.




Is IOL CHEMICALS & PHARMACEUTICALS LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$169.8m$153.7m$16.1m9.5%

How much money is IOL CHEMICALS & PHARMACEUTICALS LTD. making?

Current yearPrevious yearGrowGrow %
Making money$20.4m$54.2m-$33.7m-165.1%
Net Profit Margin7.7%22.8%--

How much money comes from the company's main activities?

3. Financial Health of IOL CHEMICALS & PHARMACEUTICALS LTD.




Comparing to competitors in the Drug Manufacturers-Specialty & Generic industry




  Industry Rankings (Drug Manufacturers-Specialty & Generic)  


Richest
#110 / 705

Most Revenue
#75 / 705

Most Profit
#65 / 705

Most Efficient
#235 / 705


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of IOL CHEMICALS & PHARMACEUTICALS LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit IOL CHEMICALS & PHARMACEUTICALS LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare IOL CHEMICALS & PHARMACEUTICALS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of 7.7% means that ₹0.08 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of IOL CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 7.7%. The company is making a profit. +1
  • The TTM is 7.7%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ7.7%TTM7.7%0.0%
TTM7.7%YOY22.8%-15.1%
TTM7.7%5Y13.3%-5.6%
5Y13.3%10Y11.2%+2.1%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ7.7%0.4%+7.3%
TTM7.7%0.3%+7.4%
YOY22.8%0.2%+22.6%
5Y13.3%-0.7%+14.0%
10Y11.2%-0.1%+11.3%
1.1.2. Return on Assets

Shows how efficient IOL CHEMICALS & PHARMACEUTICALS LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare IOL CHEMICALS & PHARMACEUTICALS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • 8.5% Return on Assets means that IOL CHEMICALS & PHARMACEUTICALS LTD. generated ₹0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of IOL CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 8.5%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 8.5%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ8.5%TTM8.5%0.0%
TTM8.5%YOY27.6%-19.1%
TTM8.5%5Y19.1%-10.5%
5Y19.1%10Y16.0%+3.1%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ8.5%0.1%+8.4%
TTM8.5%0.1%+8.4%
YOY27.6%-0.1%+27.7%
5Y19.1%-0.2%+19.3%
10Y16.0%0.1%+15.9%
1.1.3. Return on Equity

Shows how efficient IOL CHEMICALS & PHARMACEUTICALS LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare IOL CHEMICALS & PHARMACEUTICALS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • 12.0% Return on Equity means IOL CHEMICALS & PHARMACEUTICALS LTD. generated ₹0.12 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of IOL CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 12.0%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 12.0%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ12.0%TTM12.0%0.0%
TTM12.0%YOY35.3%-23.2%
TTM12.0%5Y30.9%-18.9%
5Y30.9%10Y26.1%+4.8%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ12.0%0.6%+11.4%
TTM12.0%0.4%+11.6%
YOY35.3%0.4%+34.9%
5Y30.9%-0.3%+31.2%
10Y26.1%0.1%+26.0%

1.2. Operating Efficiency of IOL CHEMICALS & PHARMACEUTICALS LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient IOL CHEMICALS & PHARMACEUTICALS LTD. is operating .

  • Measures how much profit IOL CHEMICALS & PHARMACEUTICALS LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare IOL CHEMICALS & PHARMACEUTICALS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of IOL CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y12.1%-12.1%
5Y12.1%10Y11.7%+0.3%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.5%-2.5%
TTM-1.6%-1.6%
YOY-2.7%-2.7%
5Y12.1%1.8%+10.3%
10Y11.7%0.8%+10.9%
1.2.2. Operating Ratio

Measures how efficient IOL CHEMICALS & PHARMACEUTICALS LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 1.64 means that the operating costs are ₹1.64 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of IOL CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 1.637. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.637. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.637TTM1.6370.000
TTM1.637YOY1.293+0.343
TTM1.6375Y1.452+0.185
5Y1.45210Y1.475-0.023
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6371.473+0.164
TTM1.6371.456+0.181
YOY1.2931.398-0.105
5Y1.4521.374+0.078
10Y1.4751.191+0.284

1.3. Liquidity of IOL CHEMICALS & PHARMACEUTICALS LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if IOL CHEMICALS & PHARMACEUTICALS LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 2.11 means the company has ₹2.11 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of IOL CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 2.105. The company is able to pay all its short-term debts. +1
  • The TTM is 2.105. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.105TTM2.1050.000
TTM2.105YOY3.518-1.413
TTM2.1055Y2.224-0.118
5Y2.22410Y2.064+0.160
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1051.880+0.225
TTM2.1051.901+0.204
YOY3.5182.112+1.406
5Y2.2242.182+0.042
10Y2.0641.891+0.173
1.3.2. Quick Ratio

Measures if IOL CHEMICALS & PHARMACEUTICALS LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare IOL CHEMICALS & PHARMACEUTICALS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Quick Ratio of 1.14 means the company can pay off ₹1.14 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of IOL CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 1.142. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.142. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.142TTM1.1420.000
TTM1.142YOY2.081-0.939
TTM1.1425Y1.088+0.054
5Y1.08810Y0.965+0.123
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1420.733+0.409
TTM1.1420.796+0.346
YOY2.0810.808+1.273
5Y1.0880.834+0.254
10Y0.9650.821+0.144

1.4. Solvency of IOL CHEMICALS & PHARMACEUTICALS LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of IOL CHEMICALS & PHARMACEUTICALS LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare IOL CHEMICALS & PHARMACEUTICALS LTD. to Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.29 means that IOL CHEMICALS & PHARMACEUTICALS LTD. assets are financed with 29.0% credit (debt) and the remaining percentage (100% - 29.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of IOL CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 0.290. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.290. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.290TTM0.2900.000
TTM0.290YOY0.217+0.073
TTM0.2905Y0.410-0.119
5Y0.41010Y0.470-0.060
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2900.437-0.147
TTM0.2900.424-0.134
YOY0.2170.398-0.181
5Y0.4100.398+0.012
10Y0.4700.401+0.069
1.4.2. Debt to Equity Ratio

Measures if IOL CHEMICALS & PHARMACEUTICALS LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare IOL CHEMICALS & PHARMACEUTICALS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Equity ratio of 40.9% means that company has ₹0.41 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of IOL CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 0.409. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.409. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.409TTM0.4090.000
TTM0.409YOY0.277+0.132
TTM0.4095Y0.985-0.576
5Y0.98510Y1.374-0.389
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4090.652-0.243
TTM0.4090.675-0.266
YOY0.2770.623-0.346
5Y0.9850.684+0.301
10Y1.3740.697+0.677

2. Market Valuation of IOL CHEMICALS & PHARMACEUTICALS LTD.

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings IOL CHEMICALS & PHARMACEUTICALS LTD. generates.

  • Above 15 is considered overpriced but always compare IOL CHEMICALS & PHARMACEUTICALS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • A PE ratio of 12.39 means the investor is paying ₹12.39 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of IOL CHEMICALS & PHARMACEUTICALS LTD.:

  • The EOD is 10.920. Very good. +2
  • The MRQ is 12.387. Very good. +2
  • The TTM is 12.387. Very good. +2
Trends
Current periodCompared to+/- 
EOD10.920MRQ12.387-1.467
MRQ12.387TTM12.3870.000
TTM12.387YOY7.271+5.117
TTM12.3875Y8.818+3.570
5Y8.81810Y20.579-11.761
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD10.920-0.124+11.044
MRQ12.387-0.437+12.824
TTM12.387-0.102+12.489
YOY7.27115.340-8.069
5Y8.8187.916+0.902
10Y20.5797.700+12.879
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of IOL CHEMICALS & PHARMACEUTICALS LTD..

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of IOL CHEMICALS & PHARMACEUTICALS LTD.:

  • The MRQ is 32.844. Seems overpriced? -1
  • The TTM is 32.844. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ32.844TTM32.8440.000
TTM32.844YOY5.909+26.935
TTM32.8445Y8.804+24.040
5Y8.80410Y8.8040.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ32.8440.012+32.832
TTM32.8440.010+32.834
YOY5.9090.004+5.905
5Y8.8040.010+8.794
10Y8.8040.021+8.783

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of IOL CHEMICALS & PHARMACEUTICALS LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of 1.49 means the investor is paying ₹1.49 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of IOL CHEMICALS & PHARMACEUTICALS LTD.:

  • The EOD is 1.315. Good. +1
  • The MRQ is 1.492. Good. +1
  • The TTM is 1.492. Good. +1
Trends
Current periodCompared to+/- 
EOD1.315MRQ1.492-0.177
MRQ1.492TTM1.4920.000
TTM1.492YOY2.564-1.073
TTM1.4925Y1.969-0.478
5Y1.96910Y1.967+0.002
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD1.3151.415-0.100
MRQ1.4921.586-0.094
TTM1.4922.019-0.527
YOY2.5642.230+0.334
5Y1.9691.895+0.074
10Y1.9671.505+0.462
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of IOL CHEMICALS & PHARMACEUTICALS LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--22.49422.4940%76.124-70%40.988-45%39.533-43%
Book Value Growth--1.1051.1050%1.549-29%1.541-28%1.541-28%
Book Value Per Share--237.198237.1980%214.704+10%141.606+68%123.381+92%
Book Value Per Share Growth--1.1051.1050%1.549-29%1.541-28%1.541-28%
Current Ratio--2.1052.1050%3.518-40%2.224-5%2.064+2%
Debt To Asset Ratio--0.2900.2900%0.217+34%0.410-29%0.470-38%
Debt To Equity Ratio--0.4090.4090%0.277+48%0.985-58%1.374-70%
Dividend Per Share--5.9995.9990%4.000+50%3.744+60%3.605+66%
Dividend Per Share Growth--1.5001.5000%1.376+9%1.175+28%1.175+28%
Eps--28.56128.5610%75.727-62%42.174-32%35.278-19%
Eps Growth--0.3770.3770%1.230-69%3.522-89%3.522-89%
Free Cash Flow Per Share---10.261-10.2610%46.260-122%30.189-134%26.887-138%
Free Cash Flow Per Share Growth---0.222-0.2220%0.695-132%1.292-117%1.292-117%
Free Cash Flow To Equity Per Share---10.261-10.2610%46.260-122%11.802-187%9.868-204%
Free Cash Flow To Equity Per Share Growth---0.222-0.2220%2.284-110%5.191-104%5.191-104%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---13.217--------
Intrinsic Value_10Y_min---14.264--------
Intrinsic Value_1Y_max---8.353--------
Intrinsic Value_1Y_min---8.117--------
Intrinsic Value_3Y_max---19.742--------
Intrinsic Value_3Y_min---18.740--------
Intrinsic Value_5Y_max---24.672--------
Intrinsic Value_5Y_min---23.093--------
Net Profit Margin--0.0770.0770%0.228-66%0.133-42%0.112-31%
Operating Margin----0%-0%0.121-100%0.117-100%
Operating Ratio--1.6371.6370%1.293+27%1.452+13%1.475+11%
Pb Ratio1.315-13%1.4921.4920%2.564-42%1.969-24%1.967-24%
Pe Ratio10.920-13%12.38712.3870%7.271+70%8.818+40%20.579-40%
Peg Ratio--32.84432.8440%5.909+456%8.804+273%8.804+273%
Price Per Share311.900-13%353.800353.8000%550.600-36%270.070+31%235.583+50%
Price To Total Gains Ratio10.947-13%12.41712.4170%6.872+81%7.397+68%6.463+92%
Profit Growth--0.3770.3770%1.230-69%3.646-90%3.646-90%
Quick Ratio--1.1421.1420%2.081-45%1.088+5%0.965+18%
Return On Assets--0.0850.0850%0.276-69%0.191-55%0.160-47%
Return On Equity--0.1200.1200%0.353-66%0.309-61%0.261-54%
Revenue Growth--1.1141.1140%1.040+7%1.272-12%1.272-12%
Total Gains Per Share--28.49328.4930%80.124-64%44.733-36%43.138-34%
Total Gains Per Share Growth--0.3560.3560%1.320-73%1.905-81%1.905-81%
Usd Book Value--169882560.000169882560.0000%153772460.000+10%101419332.000+68%88366363.760+92%
Usd Book Value Change Per Share--0.2740.2740%0.929-70%0.500-45%0.482-43%
Usd Book Value Per Share--2.8942.8940%2.619+10%1.728+68%1.505+92%
Usd Dividend Per Share--0.0730.0730%0.049+50%0.046+60%0.044+66%
Usd Eps--0.3480.3480%0.924-62%0.515-32%0.430-19%
Usd Free Cash Flow---7349280.000-7349280.0000%33131540.000-122%21621816.000-134%18018180.000-141%
Usd Free Cash Flow Per Share---0.125-0.1250%0.564-122%0.368-134%0.328-138%
Usd Free Cash Flow To Equity Per Share---0.125-0.1250%0.564-122%0.144-187%0.120-204%
Usd Price Per Share3.805-13%4.3164.3160%6.717-36%3.295+31%2.874+50%
Usd Profit--20455740.00020455740.0000%54236320.000-62%30205248.000-32%25256999.230-19%
Usd Revenue--264541140.000264541140.0000%237429080.000+11%211169068.000+25%190424168.911+39%
Usd Total Gains Per Share--0.3480.3480%0.978-64%0.546-36%0.526-34%
 EOD+3 -2MRQTTM+0 -0YOY+11 -305Y+13 -2910Y+15 -27

3.2. Fundamental Score

Let's check the fundamental score of IOL CHEMICALS & PHARMACEUTICALS LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1510.920
Price to Book Ratio (EOD)Between0-11.315
Net Profit Margin (MRQ)Greater than00.077
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.142
Current Ratio (MRQ)Greater than12.105
Debt to Asset Ratio (MRQ)Less than10.290
Debt to Equity Ratio (MRQ)Less than10.409
Return on Equity (MRQ)Greater than0.150.120
Return on Assets (MRQ)Greater than0.050.085
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of IOL CHEMICALS & PHARMACEUTICALS LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.612
Ma 20Greater thanMa 50337.698
Ma 50Greater thanMa 100348.841
Ma 100Greater thanMa 200354.421
OpenGreater thanClose314.800
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets19,623,000
Total Liabilities5,698,200
Total Stockholder Equity13,924,800
 As reported
Total Liabilities 5,698,200
Total Stockholder Equity+ 13,924,800
Total Assets = 19,623,000

Assets

Total Assets19,623,000
Total Current Assets10,808,200
Long-term Assets10,808,200
Total Current Assets
Cash And Cash Equivalents 35,600
Short-term Investments 1,165,000
Net Receivables 4,698,000
Inventory 4,098,900
Other Current Assets 348,800
Total Current Assets  (as reported)10,808,200
Total Current Assets  (calculated)10,346,300
+/- 461,900
Long-term Assets
Intangible Assets 35,500
Long-term Assets Other 103,000
Long-term Assets  (as reported)8,814,800
Long-term Assets  (calculated)138,500
+/- 8,676,300

Liabilities & Shareholders' Equity

Total Current Liabilities5,134,000
Long-term Liabilities564,200
Total Stockholder Equity13,924,800
Total Current Liabilities
Short Long Term Debt 427,500
Accounts payable 4,092,900
Other Current Liabilities 211,300
Total Current Liabilities  (as reported)5,134,000
Total Current Liabilities  (calculated)4,731,700
+/- 402,300
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt12,000
Long-term Liabilities Other 500
Long-term Liabilities  (as reported)564,200
Long-term Liabilities  (calculated)12,500
+/- 551,700
Total Stockholder Equity
Retained Earnings 11,037,600
Total Stockholder Equity (as reported)13,924,800
Total Stockholder Equity (calculated)11,037,600
+/- 2,887,200
Other
Capital Stock587,100
Common Stock Shares Outstanding 58,706
Net Debt 391,900
Net Invested Capital 14,352,300
Net Working Capital 5,674,200



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
> Total Assets 
8,180,947
8,216,800
9,418,800
11,755,600
16,100,900
19,623,000
19,623,00016,100,90011,755,6009,418,8008,216,8008,180,947
   > Total Current Assets 
4,135,900
4,246,700
4,842,800
6,709,400
10,222,900
10,808,200
10,808,20010,222,9006,709,4004,842,8004,246,7004,135,900
       Cash And Cash Equivalents 
163,903
7,400
134,100
1,307,600
323,400
35,600
35,600323,4001,307,600134,1007,400163,903
       Short-term Investments 
500
600
600
500
3,042,800
1,165,000
1,165,0003,042,800500600600500
       Net Receivables 
1,136,500
1,470,600
2,021,800
2,835,300
3,003,100
4,698,000
4,698,0003,003,1002,835,3002,021,8001,470,6001,136,500
       Inventory 
2,626,300
2,074,500
1,888,600
1,875,200
2,951,500
4,098,900
4,098,9002,951,5001,875,2001,888,6002,074,5002,626,300
       Other Current Assets 
328,500
667,900
749,000
657,400
274,200
348,800
348,800274,200657,400749,000667,900328,500
   > Long-term Assets 
4,055,287
4,255,400
4,538,200
5,046,200
5,878,000
8,814,800
8,814,8005,878,0005,046,2004,538,2004,255,4004,055,287
       Property Plant Equipment 
3,942,000
4,117,600
4,381,600
4,878,800
0
0
004,878,8004,381,6004,117,6003,942,000
       Intangible Assets 
0
10,000
5,800
3,500
6,100
35,500
35,5006,1003,5005,80010,0000
       Other Assets 
87,100
148,500
188,600
163,900
0
0
00163,900188,600148,50087,100
> Total Liabilities 
6,287,380
6,059,400
4,675,400
3,620,200
3,496,600
5,698,200
5,698,2003,496,6003,620,2004,675,4006,059,4006,287,380
   > Total Current Liabilities 
3,266,000
3,446,600
2,568,900
2,822,900
2,905,500
5,134,000
5,134,0002,905,5002,822,9002,568,9003,446,6003,266,000
       Short Long Term Debt 
1,615,368
1,637,600
941,200
559,900
0
427,500
427,5000559,900941,2001,637,6001,615,368
       Accounts payable 
1,498,400
1,576,100
1,202,700
1,860,900
2,388,300
4,092,900
4,092,9002,388,3001,860,9001,202,7001,576,1001,498,400
       Other Current Liabilities 
72,300
94,200
255,400
182,300
67,400
211,300
211,30067,400182,300255,40094,20072,300
   > Long-term Liabilities 
3,021,358
2,917,900
2,106,500
797,300
591,100
564,200
564,200591,100797,3002,106,5002,917,9003,021,358
       Long term Debt 
2,859,137
2,581,200
1,898,800
0
0
0
0001,898,8002,581,2002,859,137
       Capital Lease Obligations Min Short Term Debt
0
0
0
35,000
27,300
12,000
12,00027,30035,000000
       Other Liabilities 
172,100
335,900
207,700
770,000
0
0
00770,000207,700335,900172,100
       Long-term Liabilities Other 
147,125
7,800
6,500
5,100
3,800
500
5003,8005,1006,5007,800147,125
> Total Stockholder Equity
1,893,567
2,157,400
4,743,400
8,135,400
12,604,300
13,924,800
13,924,80012,604,3008,135,4004,743,4002,157,4001,893,567
   Common Stock
562,100
562,100
568,900
568,900
0
0
00568,900568,900562,100562,100
   Retained Earnings Total Equity000000
   Accumulated Other Comprehensive Income 000000
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 
104,100
97,500
176,700
161,500
0
0
00161,500176,70097,500104,100



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue21,683,700
Cost of Revenue-15,966,600
Gross Profit5,717,1005,717,100
 
Operating Income (+$)
Gross Profit5,717,100
Operating Expense-19,521,800
Operating Income2,161,900-13,804,700
 
Operating Expense (+$)
Research Development-
Selling General Administrative713,400
Selling And Marketing Expenses-
Operating Expense19,521,800713,400
 
Net Interest Income (+$)
Interest Income180,400
Interest Expense-24,300
Net Interest Income97,500156,100
 
Pretax Income (+$)
Operating Income2,161,900
Net Interest Income97,500
Other Non-Operating Income Expenses-
Income Before Tax (EBT)2,248,5002,161,900
EBIT - interestExpense = -24,300
1,676,700
1,701,000
Interest Expense24,300
Earnings Before Interest and Taxes (ebit)-2,272,800
Earnings Before Interest and Taxes (ebitda)2,705,400
 
After tax Income (+$)
Income Before Tax2,248,500
Tax Provision-571,800
Net Income From Continuing Ops1,676,7001,676,700
Net Income1,676,700
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--97,500
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
ENLT.TA
3 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of ENLT.TA.

ENLT.TA Daily Candlestick Chart
GBPEUR.FOREX
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GBPEUR.FOREX.

GBPEUR.FOREX Daily Candlestick Chart
NZDPHP.FOREX
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NZDPHP.FOREX.

NZDPHP.FOREX Daily Candlestick Chart
NZDIDR.FOREX
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NZDIDR.FOREX.

NZDIDR.FOREX Daily Candlestick Chart
MYRGBP.FOREX
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MYRGBP.FOREX.

MYRGBP.FOREX Daily Candlestick Chart
GBPMYR.FOREX
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GBPMYR.FOREX.

GBPMYR.FOREX Daily Candlestick Chart
GBPIDR.FOREX
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GBPIDR.FOREX.

GBPIDR.FOREX Daily Candlestick Chart
SGDGBP.FOREX
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SGDGBP.FOREX.

SGDGBP.FOREX Daily Candlestick Chart
GBPSGD.FOREX
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GBPSGD.FOREX.

GBPSGD.FOREX Daily Candlestick Chart
CADNOK.FOREX
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CADNOK.FOREX.

CADNOK.FOREX Daily Candlestick Chart
SVRT.TA
7 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SVRT.TA.

SVRT.TA Daily Candlestick Chart
PHTM.TA
7 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PHTM.TA.

PHTM.TA Daily Candlestick Chart
NICE.TA
7 hours ago

I found you a Golden Cross on the daily chart of NICE.TA.

NICE.TA Daily Candlestick Chart
NFTA.TA
7 hours ago

I found you a MACD Bearish Hidden Divergence on the daily chart of NFTA.TA.

NFTA.TA Daily Candlestick Chart
ICB.TA
7 hours ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of ICB.TA.

ICB.TA Daily Candlestick Chart
FRSX.TA
7 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of FRSX.TA.

FRSX.TA Daily Candlestick Chart
DCMA.TA
7 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DCMA.TA.

DCMA.TA Daily Candlestick Chart
ARD.TA
7 hours ago

I found you a Death Cross on the daily chart of ARD.TA.

ARD.TA Daily Candlestick Chart
MCRNT.TA
9 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of MCRNT.TA.

MCRNT.TA Daily Candlestick Chart